S. H. Rosen, B. Castleman, and A. A. Liebow, Pulmonary alveolar proteinosis, N Engl J Med, vol.258, pp.1123-1165, 1958.

B. C. Trapnell, K. Nakata, F. Bonella, I. Campo, M. Griese et al.,

V. Morgan, C. Cottin, and . Mccarthy, Pulmonary alveolar proteinosis, Nat Rev Dis Primers, vol.5, p.16, 2019.

R. Borie, C. Danel, M. P. Debray, C. Taille, M. C. Dombret et al., Pulmonary alveolar proteinosis, Eur Respir Rev, vol.20, pp.98-107, 2011.

F. Bonella, P. C. Bauer, M. Griese, S. Ohshimo, J. Guzman et al., Pulmonary alveolar proteinosis: new insights from a single-center cohort of 70 patients, Respir Med, vol.105, pp.1908-1924, 2011.

E. Briens, P. Delaval, M. P. Mairesse, D. Valeyre, B. Wallaert et al., Rev Mal Respir, vol.19, pp.166-82, 2002.

Y. Inoue, B. C. Trapnell, R. Tazawa, T. Arai, T. Takada et al.,

M. Tatsumi, T. Hojo, N. Ichiwata, E. Tanaka, R. Yamaguchi et al., Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan, Am J Respir Crit Care Med, vol.177, pp.752-62, 2008.

U. B. Prakash, S. S. Barham, H. A. Carpenter, D. E. Dines, and H. M. Marsh, Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review, Mayo Clin Proc, vol.62, pp.499-518, 1987.

J. F. Seymour and J. J. Presneill, Pulmonary alveolar proteinosis: progress in the first 44 years, Am J Respir Crit Care Med, vol.166, pp.215-250, 2002.

M. Griese, F. Bonella, U. Costabel, J. Blic, N. B. Tran et al., Quantitative Lipidomics in Pulmonary Alveolar Proteinosis, Am J Respir Crit Care Med, vol.200, pp.881-888, 2019.

C. Mccarthy, E. Lee, J. P. Bridges, A. Sallese, T. Suzuki et al., Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis, Nat Commun, vol.9, p.3127, 2018.

A. Sallese, T. Suzuki, C. Mccarthy, J. Bridges, A. Filuta et al.,

M. Ma, D. Wessendarp, C. Black, B. Chalk, B. C. Carey et al., Targeting cholesterol homeostasis in lung diseases, Sci Rep, vol.7, p.10211, 2017.

M. J. Thomassen, B. P. Barna, A. G. Malur, T. L. Bonfield, C. F. Farver et al.,

M. S. Dalrymple, M. Kavuru, and . Febbraio, ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis, J Lipid Res, vol.48, pp.2762-2770, 2007.

E. Stanley, G. J. Lieschke, D. Grail, D. Metcalf, G. Hodgson et al., Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology, Proc Natl Acad Sci U S A, vol.91, pp.5592-5598, 1994.

Y. Shibata, P. Y. Berclaz, Z. C. Chroneos, M. Yoshida, J. A. Whitsett et al.,

, GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through, PU.1. Immunity, vol.15, pp.557-67, 2001.

T. L. Bonfield, B. Raychaudhuri, A. Malur, S. Abraham, B. C. Trapnell et al.,

M. J. Kavuru and . Thomassen, PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor, Am J Physiol Lung Cell Mol Physiol, vol.285, pp.1132-1138, 2003.

T. Sakagami, K. Uchida, T. Suzuki, B. C. Carey, R. E. Wood et al., Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis, N Engl J Med, vol.361, pp.2679-81, 2009.

K. Uchida, D. C. Beck, T. Yamamoto, P. Y. Berclaz, S. Abe et al., GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis, N Engl J Med, vol.356, pp.567-79, 2007.

S. Jouneau, M. Kerjouan, E. Briens, J. P. Lenormand, C. Meunier et al.,

C. Chiforeanu, B. Laine-caroff, and P. Desrues, Pulmonary alveolar proteinosis, Rev Mal Respir, vol.31, pp.975-91, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01085907

D. M. Hansell, A. A. Bankier, H. Macmahon, T. C. Mcloud, N. L. Muller et al., Fleischner Society: glossary of terms for thoracic imaging, Radiology, vol.246, pp.697-722, 2008.

S. E. Rossi, J. J. Erasmus, M. Volpacchio, T. Franquet, T. Castiglioni et al., Crazy-paving" pattern at thin-section CT of the lungs: radiologic-pathologic overview, Radiographics, vol.23, pp.1509-1528, 2003.

K. Uchida, K. Nakata, B. C. Trapnell, T. Terakawa, E. Hamano et al.,

J. F. Matsushita, M. Seymour, I. Oh-eda, Y. Ishige, T. Eishi et al., High-affinity autoantibodies specifically eliminate granulocytemacrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis, Blood, vol.103, pp.1089-98, 2004.

K. Uchida, K. Nakata, B. Carey, C. Chalk, T. Suzuki et al.,

Y. Stevens, Y. Inoue, B. C. Yamada, and . Trapnell, Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis, J Immunol Methods, vol.402, pp.57-70, 2014.

T. L. Bonfield, M. S. Kavuru, and M. J. Thomassen, Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis, Clin Immunol, vol.105, pp.342-50, 2002.

T. Kitamura, K. Uchida, N. Tanaka, T. Tsuchiya, J. Watanabe et al., Serological diagnosis of idiopathic pulmonary alveolar proteinosis, Am J Respir Crit Care Med, vol.162, pp.658-62, 2000.

K. Uchida, K. Nakata, T. Suzuki, M. Luisetti, M. Watanabe et al.,

, Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects, Blood, vol.113, pp.2547-56, 2009.

M. S. Kavuru, A. Malur, I. Marshall, B. P. Barna, M. Meziane et al., An open-label trial of rituximab therapy in pulmonary alveolar proteinosis, Eur Respir J, vol.38, pp.1361-1368, 2011.

F. C. Lin, G. D. Chang, M. S. Chern, Y. C. Chen, and S. C. Chang, Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis, Thorax, vol.61, pp.528-562, 2006.

K. N. Lee, D. L. Levin, W. R. Webb, D. Chen, M. L. Storto et al., Pulmonary alveolar proteinosis: high-resolution CT, chest radiographic, and functional correlations, Chest, vol.111, pp.989-95, 1997.

R. Tazawa, T. Ueda, M. Abe, K. Tatsumi, R. Eda et al., Inhaled GM-CSF for Pulmonary Alveolar Proteinosis, N Engl J Med, vol.381, pp.923-955, 2019.

B. C. , Clinical features of autoimmune pulmonary alveolar proteinosis from a large international patient cohort: baseline data from the IMPALA trial, Eur Respir J, p.5328, 2019.

A. D. Punatar, S. Kusne, J. E. Blair, M. T. Seville, and H. R. Vikram, Opportunistic infections in patients with pulmonary alveolar proteinosis, J Infect, vol.65, pp.173-182, 2012.

M. Akira, Y. Inoue, T. Arai, C. Sugimoto, S. Tokura et al., Osaka Respiratory Diseases Symposia. Pulmonary Fibrosis on High-Resolution CT of Patients With Pulmonary Alveolar Proteinosis, AJR Am J Roentgenol, vol.207, pp.544-51, 2016.

M. Luisetti, P. Bruno, Z. Kadija, T. Suzuki, S. Raffa et al.,

E. Mariani, B. C. Pozzi, S. Trapnell, and . Mariotta, Relationship between diffuse pulmonary fibrosis, alveolar proteinosis, and granulocyte-macrophage colony stimulating factor autoantibodies, Respir Care, vol.56, pp.1608-1618, 2011.

S. Marchand-adam, B. Diot, P. Magro, A. Muret, C. Guignabert et al., Pulmonary alveolar proteinosis revealing a telomerase disease, Am J Respir Crit Care Med, vol.188, pp.402-406, 2013.

X. Sui, Q. Du, K. F. Xu, X. Tian, L. Song et al., Quantitative assessment of Pulmonary Alveolar Proteinosis (PAP) with ultradose CT and correlation with Pulmonary Function Tests (PFTs), PLoS One, vol.12, p.172958, 2017.

S. Tokura, M. Akira, T. Okuma, R. Tazawa, T. Arai et al.,

T. Hirose, K. Takada, H. Nakata, Y. Ishii, M. Kasahara et al., A Semiquantitative Computed Tomographic Grading System for Evaluating Therapeutic Response in Pulmonary Alveolar Proteinosis, Ann Am Thorac Soc, vol.14, pp.1403-1414, 2017.

T. E. Robinson, B. C. Trapnell, M. L. Goris, L. M. Quittell, and D. N. Cornfield, Quantitative analysis of longitudinal response to aerosolized granulocyte-macrophage colony-stimulating factor in two adolescents with autoimmune pulmonary alveolar proteinosis, Chest, vol.135, pp.842-850, 2009.

R. Tazawa, B. C. Trapnell, Y. Inoue, T. Arai, T. Takada et al.,

K. Kasahara, M. Tatsumi, H. Hojo, M. Ishii, N. Yokoba et al.,

K. Tsuchihashi, M. Morimoto, M. Akira, J. Terada, M. Otsuka et al., Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis, Am J Respir Crit Care Med, vol.181, pp.1345-54, 2010.

C. Mccarthy, M. Kokosi, and F. Bonella, Shaping the future of an ultra-rare disease: unmet needs in the diagnosis and treatment of pulmonary alveolar proteinosis, Curr Opin Pulm Med, vol.25, pp.450-458, 2019.

J. Ramirez, W. Nyka, and L. J. Mc, Pulmonary alveolar proteinosis. Diagnostic technics and observations, N Engl J Med, vol.268, pp.165-71, 1963.

J. D. Smith, J. E. Millen, P. Safar, and E. D. Robin, Intrathoracic pressure, pulmonary vascular pressures and gas exchange during pulmonary lavage, Anesthesiology, vol.33, pp.401-406, 1970.

P. L. Shah, D. Hansell, P. R. Lawson, K. B. Reid, and C. Morgan, Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis, Thorax, vol.55, pp.67-77, 2000.

P. Gay, B. Wallaert, S. Nowak, J. Yserbyt, S. Anevlavis et al.,

B. Menard, T. Maitre, H. Vandemoortele, A. Dutau, A. Briault et al., Groupe d''Endoscopie Thoracique de Langue. Efficacy of Whole-Lung Lavage in Pulmonary Alveolar Proteinosis: A Multicenter International Study of GELF, Respiration, vol.93, pp.198-206, 2017.

I. Campo, M. Luisetti, M. Griese, B. C. Trapnell, F. Bonella et al.,

A. Iotti, C. Tinelli, G. Rodi, and W. L. Group, A Global Survey on Whole Lung Lavage in Pulmonary Alveolar Proteinosis, Chest, vol.150, pp.251-254, 2016.

G. P. Genereux, Lipids in the lungs: radiologic-pathologic correlation, J Can Assoc Radiol, vol.21, pp.2-15, 1970.

G. Michaud, C. Reddy, and A. Ernst, Whole-lung lavage for pulmonary alveolar proteinosis, Chest, vol.136, pp.1678-81, 2009.

G. Sheng, P. Chen, Y. Wei, J. Chu, X. Cao et al., Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocytemacrophage colony-stimulating factor: a meta-analyses, Eur Respir J, vol.19, pp.1503-1509, 2009.

A. Malur, M. S. Kavuru, I. Marshall, B. P. Barna, I. Huizar et al., Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis, Respir Res, vol.13, p.46, 2012.

B. Soyez, R. Borie, C. Menard, J. Cadranel, L. Chavez et al., Rituximab for auto-immune alveolar proteinosis, a real life cohort study, Respir Res, vol.19, p.74, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01791591

B. Garber, J. Albores, T. Wang, and T. H. Neville, A plasmapheresis protocol for refractory pulmonary alveolar proteinosis, Lung, vol.193, pp.209-220, 2015.

A. Jezequel, M. Kerjouan, M. Lederlin, C. Laine-caroff, C. Camus et al., Plasmapheresis failure in the treatment of auto-immune pulmonary alveolar proteinosis, Rev Mal Respir, vol.34, pp.240-243, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01526427

M. S. Kavuru, T. L. Bonfield, M. J. Thomassen, and G. Plasmapheresis, Am J Respir Crit Care Med, vol.167, 1036.

M. Luisetti, G. Rodi, C. Perotti, I. Campo, F. Mariani et al., Plasmapheresis for treatment of pulmonary alveolar proteinosis, Eur Respir J, vol.33, pp.1220-1222, 2009.

H. Yu, X. Sun, Y. Wang, Z. Xu, and H. Huang, Whole lung lavage combined with

, Granulocyte-macrophage colony stimulating factor inhalation for an adult case of refractory pulmonary alveolar proteinosis, BMC Pulm Med, vol.14, p.87, 2014.

L. A. Parker and D. B. Novotny, Recurrent alveolar proteinosis following double lung transplantation, Chest, vol.111, pp.1457-1465, 1997.

A. A. Gal, J. A. Bryan, K. R. Kanter, and E. C. Lawrence, Cytopathology of pulmonary alveolar proteinosis complicating lung transplantation, J Heart Lung Transplant, vol.23, pp.135-143, 2004.

S. A. Yousem, Alveolar lipoproteinosis in lung allograft recipients, Hum Pathol, vol.28, pp.1383-1389, 1997.

S. Ikeda, A. Sekine, T. Baba, T. Katano, H. Yamakawa et al.,

T. Matsumura, T. Takemura, and . Ogura, Secondary pulmonary alveolar proteinosis predominant in the transplanted lung in patients with idiopathic interstitial pneumonia: an autopsy case, J Thorac Dis, vol.10, pp.351-355, 2018.

S. L. Pedroso, L. S. Martins, S. Sousa, A. Reis, L. Dias et al.,

A. Sarmento and . Cabrita, Pulmonary alveolar proteinosis: a rare pulmonary toxicity of sirolimus, Transpl Int, vol.20, pp.291-297, 2007.

K. R. Flaherty, A. U. Wells, V. Cottin, A. Devaraj, S. L. Walsh et al., I. T. Investigators. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases, vol.381, pp.1718-1745, 2019.